Researcher profile
Harry Moultrie
Public evidence
2 connected articles
Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost after Prime with Ad26.COV2.S among Healthcare Workers in South Africa: the single-arm, open-label, Phase 3 SHERPA Study2024 · medRxivThe National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths in South Africa2022 · medRxiv
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.